IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
0.318
-0.002 (-0.75%)
At close: Nov 22, 2024, 4:00 PM
0.328
+0.011 (3.34%)
After-hours: Nov 22, 2024, 6:44 PM EST
IN8bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 23 | 60 | 57 | 82 | - | - | |
Market Cap Growth | -61.56% | 5.43% | -31.25% | - | - | - | |
Enterprise Value | 24 | 52 | 34 | 44 | - | - | |
Last Close Price | 0.32 | 1.38 | 2.31 | 4.39 | - | - | |
PB Ratio | 1.73 | 2.39 | 2.49 | 2.16 | - | - | |
P/TBV Ratio | 1.47 | 2.39 | 2.49 | 2.16 | - | - | |
Debt / Equity Ratio | 0.64 | 0.20 | 0.26 | 0.06 | 0.01 | - | |
Quick Ratio | 1.10 | 3.95 | 3.12 | 16.41 | 7.00 | 0.94 | |
Current Ratio | 1.84 | 4.57 | 3.82 | 17.28 | 7.05 | 1.18 | |
Return on Equity (ROE) | -241.97% | -125.90% | -93.64% | -51.87% | -91.01% | -172.31% | |
Return on Assets (ROA) | -92.78% | -56.81% | -47.37% | -29.01% | -48.53% | -90.14% | |
Return on Capital (ROIC) | -105.53% | -64.89% | -51.52% | -31.00% | -56.36% | -106.27% | |
Earnings Yield | -138.46% | -50.29% | -50.39% | -17.80% | - | - | |
FCF Yield | -109.45% | -40.12% | -49.16% | -16.78% | - | - | |
Buyback Yield / Dilution | -56.99% | -42.43% | -110.32% | -191.59% | -7.24% | -1.65% | |
Total Shareholder Return | -56.99% | -42.43% | -110.32% | -191.59% | -7.24% | -1.65% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.